Screening compound: TZDSMCMOIBRKKW-UHFFFAOYSA-N

Screening compound: TZDSMCMOIBRKKW-UHFFFAOYSA-N
Screening compound: TZDSMCMOIBRKKW-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
TZDSMCMOIBRKKW-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-6046

Molecular Formula

C16H19N3O3 (C16 H19 N3 O3)

Compound Name

ethyl 4-isopropyl-2-oxo-1,2,3,4-tetrahydropyrimido[1,2-a][1,3]benzimidazole-3-carboxylate

IUPAC name

ethyl 11-oxo-13-(propan-2-yl)-1810-triazatricyclo[7.4.0.0^{27}]trideca-2(7)358-tetraene-12-carboxylate

SMILES

CCOC(C(C(C(C)C)n1c(N2)nc3c1cccc3)C2=O)=O

InChI

InChI=1S/C16H19N3O3/c1-4-22-15(21)12-13(9(2)3)19-11-8-6-5-7-10(11)17-16(19)18-14(12)20/h5-9,12-13H,4H2,1-3H3,(H,17,18,20)

InChI Key

TZDSMCMOIBRKKW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06193721

TZDSMCMOIBRKKW-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Soluble Diversity Library (15920 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with TZDSMCMOIBRKKW-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound TZDSMCMOIBRKKW-UHFFFAOYSA-N?
Check Price and Availability of TZDSMCMOIBRKKW-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of TZDSMCMOIBRKKW-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for TZDSMCMOIBRKKW-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for TZDSMCMOIBRKKW-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of TZDSMCMOIBRKKW-UHFFFAOYSA-N available by request